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Introduction
Surgical resection is considered to be the only potentially curative option for patients with pancreatic neuroendocrine tumors. Frequency of surgery complications varies from 33% to 52%, while pancreatic fistulas occur in 8-19% of cases (1) (2) (3) (4) (5) . Therefore, it is necessary to search for alternative methods of treatment in order to achieve better outcomes. In recent literature, single cases of local ablative techniques with different modalities have been described including ethanol ablation, radiofrequency ablation (RFA) and microwave ablation (MWA). However, definite indications for such treatment options as an alternative to conventional surgery have not been defined yet. In most cases ablation is applied in patients with poor performance status or in cases of metastatic functional neuroendocrine tumors in order to manage hormonal syndrome. We present our experience of microwave ablation technique for hormonally active pancreatic tumors as a novel organsparing and minimally invasive method of treatment.
Original Article
The role of microwave ablation in management of functioning pancreatic neuroendocrine tumors
Methods
The principle of microwave ablation is cell death via coagulation necrosis. Electromagnetic waves produce the agitation of water molecules and induce frictional heating of the tumor tissue. This method is similar to radiofrequency ablation, however, MWA offers more benefits and has several other advantages. The effect of MWA does not depend on tissue impedance, it does not have electrical circuit, does not require cooling. MWA has less susceptibility to heat-sinks as a result of the shorter wavelength comparing with RFA. More effective transfer of the microwave energy to the biological tissues reduces heating time, affecting the necessary zone by high temperature. Water vaporization and charring do not limit ablation area as it is with RFA due to electrical insulation. As a result, the microwave field penetrates the tissue deeper. This feature also significantly reduces the time of ablation (6) (7) (8) .
Sechenov University has an experience of treating more than 400 patients with hormone-producing tumors of the pancreas, seven of which underwent microwave ablation ( Indications for MWA for patients No. 1-4 were tumor location in the pancreatic head and high risk of intra-and postoperative complications due to severe general somatic state. US-guided percutaneous MWA was performed in patient No. 1.
Patient No. 2 already had enucleation of pancreatic insulinoma located in the head 8 years ago. Afterwards another insulinoma appeared in pancreatic head, minilaparotomy approach for MWA was used in order to provide safe access to the pancreatic head. MWA approaches for patient No. 3 and No. 4 were laparotomy and laparoscopy respectively.
Patients No. 5 and No. 6 were relatively young, and both had neuroendocrine tumors deeply in the tissue of pancreatic head close to the main duct. Therefore, tumor enucleation could not be performed, and MWA was chosen as a treatment option.
Patient No. 7 had two MEN-1 associated neuroendocrine tumors located deeply in the head of pancreatic tissue. This patient underwent a distal pancreatectomy due to malignant PP-oma 3 years before. Taking into account the localization of the tumors surgical excision meant total pancreatectomy. Patient refused to undergo total pancreatectomy, thus as an alternative to aggressive surgery we suggested MWA to be performed.
Results
Clinical presentation of organic hyperinsulinism in all patients who underwent MWA regressed during the first 3 days, subsequently all of them were normoglycaemic. The average patient observation time is 31 months (min = 11, max =42). Patient No. 1 died 2 months later due to myocardial infarction. Other patients are alive and asymptomatic without any evidence of tumor recurrence.
Imaging studies show tumor replacement with inflammatory infiltrate and its transformation to the fibrosis (Figure 1) . Table 2 shows clinical outcomes after microwave ablation.
In the postoperative period, two patients had pseudocysts in the ablation zone. Both of them were asymptomatic. Patient No. 6 had a pseudocyst 4 cm in diameter, which shrunk progressively and disappeared 2 years later without any treatment (Figure 2) .
Another pseudocyst was detected on imaging 10 months after MWA in Patient No. 3. Because of its large size (8 cm in diameter), we managed it with minimally invasive technique. Patient No.7 was diagnosed with postoperative pancreatic fistula grade B 1 month after MWA was performed. We managed it successfully with US-guided percutaneous drainage.
Discussion
Pancreatic neuroendocrine tumors represent 1-2% of all pancreatic lesions. Major part of pNETs are welldifferentiated tumors grade 1 or 2 according to the WHO classification. Insulinomas are the most common functioning NETs, 80% of which are up to 1.5 cm (9,10). Surgical resection is considered to be the only 
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potentially curative option for patients with pancreatic neuroendocrine tumors and because of its some limitations and postoperative-related complications, there is a profound interest in finding and developing better and more effective methods of treatment.
In our literature review, we have found that there are only few publications focusing on methods of local destruction as a potential alternative to conventional surgical treatment of insulin-producing NETs ( Table 3) .
Among 43 described patients, ethanol ablation was applied to 31, RFA to 11 and MWA was used in one patient. Whereas a complete reduction of hypoglycemic symptoms was achieved in 38 patients, a reduction of frequency of the attacks was made in three patients and only one patient did not show any beneficial result. In two cases, recurrent interventions were needed in order to achieve stable clinical results. Complications grade 3-4 by Clavien-Dindo classification occurred in three patients after ethanol ablation, two of whom had pseudocyst and one had intraoperative bleeding. Indications for local destruction methods of pancreatic insulinomas, described by the authors, absolutely fit our conception of MWA use in the following situations:
(I) severe general somatic state of the patient, which does not allow the traditional surgical interventions to be performed; (II) patient refuses to undergo surgery; (III) high risk of intra-and postoperative complications; (IV) applying ablation techniques for pancreatic head lesions as an organ-sparing alternative to Whipple procedure and total pancreatectomy. In addition, among the large number of local ablative techniques used for liver metastasis, the most frequent one is microwave ablation since it has numerous advantages.
The advantages are the following: short time required for the procedure compared to RFA, an average 10 minutes against 40 with RFA; less effect of blood vessels heat remove; simpler technical design that does not require a cooling circuit; lower cost compared to RFA; wider active heating zone, higher temperatures in the target zone for shorter processing times and no heat sink effect (7, 36) .
There have been only two publications reported in the literature, describing the use of microwave ablation in cases with insulinomas. Chen and co-authors resorted to MWA to stop hypoglycemia in a patient with comorbidities, as in such case it is a contraindication for surgery (24) . A group of authors from Chicago performed MWA of a liver metastases of a malignant insulinoma to control hypoglycemia (37) .
Our experience has demonstrated a complete control of hypoglycemia in all patients after MWA of pancreatic head insulinomas. This tumor localization is the most difficult and challenging one for surgical excision. In the case when the tumor was close to duodenum or pancreatic duct, ablation was performed from several points to reduce the risk of damage. We had 2 complications grade IIIa (Clavien-Dindo) and the rest 5 patients did not require any specific treatment in the postoperative period. None presented neither with tumor recurrence nor hypoglycemic syndrome.
Conclusions
The role of local destruction methods in the treatment of non-metastatic neuroendocrine tumors of pancreas has not been defined yet. There is no doubt that surgery still plays a main role in the treatment of this group of patients. Application of alternative methods can be done in single cases only with strict indications, thus making 
